Cited by 17Dupuytren's Contracture and TreatmentsSexual function and dysfunction studiesMesenchymal stem cell research

Intratunical injection of rat-derived bone marrow mesenchymal stem cells prevents fibrosis and is associated with increased Smad7 expression in a rat model of Peyronie’s disease

Open access
Wang, Wenting, Ding, Weifang, Zhang, Xuebao, Wu, Shuang, Yu, Tianxi, Cui, Xin, Xie, Yaqi, Yang, Diandong +1 more·2022·Stem Cell Research & Therapy

Abstract

Objective: Peyronie’s disease (PD) is a fibrotic disorder of the penis, but effective treatments are lacking. Here, we observed the effects of rat-derived bone marrow mesenchymal stem cells (BMSCs) injection in the active phase and chronic phase in a rat model of PD, and the possible mechanism was analysed with fibroblasts derived from rat penile tunica albuginea (TA). Methods: Thirty-two male Sprague-Dawley rats were divided into four groups. In sham group, the rats were injected with 50 µL of vehicle. In the PD group, the rats were injected with 50 µg TGF-β1. In the PD + BMSCs early treatment group, the rats were injected with 50 µg TGF-β1 and injected with 1 × 10 6 BMSCs after 1 day. In the PD + BMSCs late treatment group, the rats were injected with 50 µg TGF-β1 and injected with 1 × 10 6 BMSCs after 28 days. Twenty-seven days after the last injection, the erectile function of the rats was measured, and then, penile fibrosis was analysed by histology and western blot. In vitro, fibroblasts derived from rat penile TA were used to identify a possible antifibrotic mechanism of BMSCs, and a Smad7 expression vector was used as a positive control. Fibroblasts were pretreated with the Smad7 expression vector or BMSCs for 48 h and then activated with 10 ng/mL TGF-β1 for 24 h. Cells viability was assessed, and Smad7, collagen 3, elastase-2B and osteopontin expression levels were analysed by immunofluorescence and western blot. Furthermore, fibroblasts were transfected with Smad7 siRNA or scramble control to observe whether the effects of BMSCs could be offset. Results: Erectile function obviously improved, and fibrosis of penile TA was prevented after BMSCs treatment compared with that in the rats with PD. Furthermore, the effects of BMSCs treatment in the active phase were better than those in the chronic phase. After cocultured with BMSCs, cell viability was not affected, Smad7 expression was upregulated, and collagen 3, elastase-2B and osteopontin levels were decreased in the TGF-β1-treated fibroblasts. After transfection with Smad7 siRNA, the antifibrotic effects of BMSCs were offset. Conclusions: The antifibrotic effects of BMSCs treatment in the active phase of the PD rat model were better than those in the chronic phase. A possible mechanism of BMSCs treatment was related to increased Smad7 expression, suggesting a possible effective and safe procedure for the treatment of PD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13287-022-03090-w

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Current therapeutic approaches for PD often target the fibrotic process to mitigate its impact on penile function and patient quality of life.

    “Current therapeutic approaches for PD often target the fibrotic process to mitigate its impact on penile function and patient quality of life.112”

    From Research advances in Peyronie's disease: a comprehensive review on genomics, pathways, phenotypic manifestation, and therapeutic targets. (2024) · cites this paper as [112]

    The Introduction describes PD as a fibrotic disorder that affects quality of life, and the Results report that experimental BMSC treatment suppressed fibrosis and improved erectile-function measures in rats. But the Introduction lists current treatments without saying they often target fibrosis; it instead calls for a new treatment that inhibits or reverses fibrosis. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

5 of the 31 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. [15]Mostafavi FS Razavi S Mardani M Comparative study of microtubule-associated protein-2 and glial fibrillary acidic proteins during neural induction of human bone marrow mesenchymal stem cells and adipose-derived stem cells Int J Prev Med 2014 5 5 584 595 24932390 PMC4050679
  2. [19]Chung PH Han TM Rudnik B Das AK Peyronie’s disease: what do we know and how do we treat it? Can J Urol 2020 27 S3 11 19 32875997

Cited by

Sorted by citations

Authors
Wang, W., Ding, W., Zhang, X., Wu, S., Yu, T., Cui, X., Xie, Y., Yang, D., & Lin, C.
Affiliations
Qingdao University (CN)
Corresponding author
  • Yang, Diandong
  • Lin, Chunhua
Venue
Stem Cell Research & Therapy
Published
2022-07-30
Volume
13
Issue
1
Pages
390-390
ISSN
1757-6512 (ISSN-L)
OpenAlex
W4288749642
Cited by
17
References
31
Citations by year
2025: 1 · 2024: 13 · 2023: 3
FWCI
3.09
Type
journal article
Language
en
Open access
Locations
  • Stem Cell Research & Therapy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Taishan scholar program (Tsqn202103198)
  • Natural Science Foundation of Shandong Province (ZR2019MH132)
  • Yantai Key Research and Development Project (2019MSGY135, 2020MSGY079)
Topics
  • Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
Keywords
Peyronie's disease, bone marrow mesenchymal stem cells, penile fibrosis, Smad7, TGF-β1, antifibrotic therapy, erectile function, type III collagen, osteopontin, stem cell therapy, rat model, treatment timing
MeSH terms
Animals, Bone Marrow Cells, Disease Models, Animal, Fibrosis, Humans, Erectile Dysfunction, Male, Pancreatic Elastase, Penile Induration, Rats, Sprague-Dawley, RNA, Small Interfering, Rats, Smad7 Protein, Osteopontin, Transforming Growth Factor beta1, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review